Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
acute disseminated encephalomyelitis
acute necrotizing encephalitis
acyclovir
advances in neurology
adverse drug reaction
altered states of consciousness
alternative medicine
amyotrophic lateral sclerosis
anticonvulsants
antiviral agents
asymptomatic
attention span
autoimmune disease
behavior modification
behavioral disorder
bladder dysfunction
blood dyscrasias, neurologic findings with
brain biopsy
brain scan
breast feeding
calcification, intracranial
caloric testing
cancer, cerebrovascular accident complicating patients with
carcinoma
carcinoma of lung
cataracts, congenital
cerebral infarction, hemorrhagic
cerebral palsy
cerebral venous thrombosis
cerebral venous thrombosis, deep
cerebrospinal fluid, cytology
cerebrospinal fluid, gammaglobulin of
cerebrospinal fluid, xanthochromia of
cerebrovascular accident
cerebrovascular accident, rehabilitation of
cerebrovascular accident, thrombolytic agents in treatment
children
chills
chorioretinitis
cladribine
complementary medicine
compliance
complications
concentration, impaired
concussion
controversies in neurology
conversion reaction
cop 1
cost
cost effectiveness
cyst, porencephalic
cytomegalic inclusion disease
cytosine arabinoside
dementia
demyelinating disease
depression
depression, psychotic
dermatomyositis
diabetes mellitus
diagnostic criteria
disability rating scale, neurological
disability, neurological
dizziness
drug induced neurologic disorders
dural arteriovenous malformation
dural sinus thrombosis
efficacy
electroencephalogram
electron microscopy
electronystagmography
electronystagmography, abnormal
emotional lability
encephalitis
encephalitis, brainstem
encephalitis, clinical picture and treatment of
encephalitis, diagnosis of
encephalitis, viral
encephalitis, viral-causes of
epidemiology of neurology
episodic disorders
evidence-based research
extinction on double simultaneous stimulation
eye movement, disorders of
facial nerve palsy
facial weakness
fatigue
fever
fibrinolytic agents
fibrinolytic agents, complications
fibromyalgia
fingolimod
flu-like illness
gadolinium
gag reflex, depressed
gait disorder
gammaglobulin therapy, intravenous
glioblastoma multiforme(astrocytoma Gr.III)
Guillain Barre syndrome
head injury
headache
herpes labialis
herpes simplex encephalitis
herpes simplex encephalitis, differential diagnosis of
herpes simplex encephalitis, recurrent
herpes simplex encephalitis, treatment of
herpes simplex myelitis
herpes simplex virus
herpes simplex virus infection, immunosuppressed patient
herpes simplex virus, human nervous system and
herpes simplex virus, localization of
herpes simplex virus, malignancy with
herpes simplex virus, pathogenesis of
herpes simplex virus, pathology of
herpes simplex, neurocutaneous lesions in
herpes virus
herpes zoster
herpes, genital
hormone replacement
human herpesvirus 6
hydrocephalus
hypochondriasis
hypoglycorrhachia
iatrogenic neurologic disorders
imbalance
imbalance, postural
immunofluorescent exam of CSF cells
immunology and the nervous system
immunomodulation
immunosuppression
immunosuppressive agents
inclusion bodies, intranuclear
inclusion body myositis
infectious mononucleosis
interferon
interferon antibodies
interferon beta 1-a
interferon beta 1-b
interferon inducer
internet
intracerebral hemorrhage
intracranial pressure, increased
intrauterine infection, viral
intrauterine infection, viral of CNS
iododeoxyuridine
leukopenia
level of consciousness, decreased
limbic encephalitis
limbic system
liver function enzymes
lymphopenia
malformation, CNS, congenital
marihuana
medical-legal aspects of neurology
meningitis
meningitis, aseptic
mental status, abnormal
methotrexate
microcephaly
micropthalmia
mitoxantrone
monoamines
monoamines, brain
monoclonal antibodies
motor dysfunction
motor neuron disease
movement disorder
movement disorder, psychogenic
MRI
MRI, abnormal
MRI, ADC maps
MRI, contrast enhanced
MRI, demyelinating disease
MRI, diffusion weighted
MRI, early changes in CVA
MRI, incidental finding
MRI, serial
MRI, volumetry
multiple sclerosis
multiple sclerosis, acute
multiple sclerosis, asymptomatic
multiple sclerosis, diagnosis of
multiple sclerosis, disability status scale
multiple sclerosis, monosymptomatic
multiple sclerosis, prognosis
multiple sclerosis, radiologically isolated syndrome
multiple sclerosis, relapsing
multiple sclerosis, telling patient diagnosis of
multiple sclerosis, treatment of
muscle pain
muscular dystrophy
myasthenia gravis
myasthenia gravis, treatment of
myasthenic syndrome
myasthenic syndrome, treatment of
myelitis
myofascial pain syndrome
myopathy
natalizumab
neglect
neoplasm, primary intracerebral
neurologic complications of, systemic cancer
neurologic consultation
neurologic disease
neurologic disease, diagnoses of
neurologic disease, incurable
neurologic evaluation
neurologist
neuropathy
neuropathy, multifocal
neuropathy, peripheral, treatment
nystagmus
nystagmus, positional
ocular dysmetria
optic atrophy
optokinetic nystagmus(O.K.N.)
optokinetic nystagmus, abnormal
oral contraceptives
oral contraceptives, neurologic complications with
outcome research
oxybutynin
pathologic reflex
patient information and support
Persistent postural-perceptual dizziness
personality change
physician as patient
plasmapheresis
pleocytosis of cerebrospinal fluid
pneumonia
polyinosinic cytidic acid(poly IC)
polyneuropathy, chronic inflammatory demyelinating
practice guidelines
precipitating factors
pregnancy, neurologic complications in
pressure sores
prethrombotic state
primary intracranial hypotension
prognosis
progressive multifocal leucoencephalopathy
psychiatric disorder
psychiatric problems in neurologic disorders
psychomotor retardation
psychosis
pursuit eye movements
quality of life
rehabilitation for neurologic disorders
remote effect of cancer on the nervous system
review article
risk factors
rubella virus
saccadic eye movements
seizure
seizure, psychomotor-temporal lobe
seizure, treatment of
selective serotonin reuptake inhibitors
serologic testing
serotonin norepinephrine reuptake inhibitors
serum glutamic oxaloacetic transaminase
sexual dysfunction in neurologic disease
spasticity
spatial neglect
spinal cord
spinal cord, injury of
spinal cord, injury, complications with
spinal cord, injury, functional capacity of patient with
spinal cord, injury, prognosis in
spinal cord, injury, sexual dysfunction in
stem cell tourism
stem cell transplantation
steroid
steroid therapy, CNS treatment and complications with
stiff man syndrome
subacute myelo-opticoneuropathy(S.M.O.N.)complex
subspecialist
subtemporal decompression
systemic illness
talk
teleconsulting
telemedicine
teleneurology
telestroke
tender points
thoracic outlet syndromes
tissue plasminogen activator, intravenous
transplacental virus infections
trauma
treatment of neurologic disorder
trigeminal neuralgia
urinary tract infection
viral infection
viral infection, CNS
walking
weakness
workers' compensation
Showing articles 250 to 300 of 4627 << Previous Next >>

Longitudinally Extensive Transverse Myelitis with and Without Aquaporin 4 Antibodies
JAMA Neurol 70:1375-1381, Kitley, J.,et al, 2013

An Expanded Role for Neuroimaging in the Evaluation of Memory Impairment
AJNR 34:2075-2082, Desikan, R.S.,et al, 2013

Clinical Features of MS Associated with Leber Hereditary Optic Neuropathy mtDNA Mutations
Neurol 81:2073-2081, Pfeffer, G.,et al, 2013

Functional Impairment in Progressive Supranuclear Palsy
Neurol 80:380-384, Duff, K.,et al, 2013

Tumor Necrosis Factor-Alpha Inhibitors: An Overview of Adverse Effects
UpToDate January, Stone, J.H., 2013

Daclizumab High-Yield Process in Relapsing-Remitting Multiple Sclerosis (SELECT): A Randomised, Double-Blind, Placebo-Controlled Trial
Lancet 381:190-194, Gold, R.,et al, 2013

Varicella-Zoster Virus Acute Myelitis in a Patient with MS Treated with Natalizumab
Neurol 80:1812-1813, Yeung, J.,et al, 2013

Aquaporin-4 Antibody-Negative Neuromyelitis Optica
Neurol 80:2194-2200,2176, Maringer, R.,et al, 2013

Aquaporin-4 Antibody-Positive Cases Beyond Current Diagnosis Criteria for NMO Spectrum Disorders
Neurol 80:2210-2216, Sato, D.,et al, 2013

Daclizumab High-Yield Process in Relapsing-Remitting Multiple Sclerosis (SELECT): A Randomised, Double-Blind, Placebo-Controlled Trial
Lancet 381:2167-2175, Gold, R.,et al, 2013

Interferon beta for Secondary Progressive Multiple Sclerosis: A Systematic Review
JNNP 84:420-426, La Mantia, L.,et al, 2013

Clinicopathologic Conference, Blind and Confused, Neuromyelitis Optica Spectrum Disorder
JAMA Neurol 70:932-936, Sharma, V.,et al, 2013

Extensive Vasogenic Edema of Anti-Aquaporin-4 Antibody-Related Brain Lesions
Mult Scler 15:1113-1117, Matsushita, T.,et al, 2013

Brain Abnormalities as an Initial Manifestation of Neuromyelitis Optica Spectrum Disorder
MSJ 17:1107-1112, Kim, W.,et al, 2013

Clinical Spectrum of CNS Aquaporin-4 Autoimmunity
Neurol 78:1179-1185, Kim, S.,et al, 2013

Differential Diagnosis of Neuromyelitis Optica Spectrum Disorders
Brain Neurol 62:953-960, Tanaka, T., 2013

Aquaporin-4 Antibody-Negative Neuromyelitis Optica
Neurol 80:2194-2200, 2176, Marignier, R.,et al, 2013

Spinal Cord Lesions in Patients with Clinically Isolated Syndrome
Neurol 80:69-75, Sombekke, M.,et al, 2013

The Thalamus and Multiple Sclerosis
Neurol 80:210-219, Minagar, A.,et al, 2013

Location of Brain Lesions Predicts Conversion of Clinically Isolated Syndromes to Multiple Sclerosis
Neurol 80:234-241, Giorgio, A.,et al, 2013

Cerebral Venous Thrombosis after High Dose Steroid in Multiple Sclerosis: A Case Report
Hippokratia 17:88-90, Gazioglu, S.,et al, 2013

Central Nervous System Lymphoma Initial Diagnosed as Tumefective Multiple Sclerosis after Brian Biopsy
Intern Med 52:483-488, Ohe, Y.,et al, 2013

Anti-Aquaporin-4 Antibody-Seronegative NMO Spectrum Disorder with Balos Concentric Lesions
Intern Med 52:1517-1521, Masuda, H.,et al, 2013

Herpes Encephalitis During Natalizumab Tretament in Multiple Sclerosis
Mult Scler J 18:909-911, Kwiatkowski, A.,et al, 2012

Brain Abnormalities in Neuromyelitis Optica Spectrum Disorder
Multiple Sclerosis International ID 735486, Kim, W.,et al, 2012

The Differential Diagnosis of Longitudinally Extensive Transverse Myelitis
Mult Scler 18:271-285, Kitley, J.L.,et al, 2012

Brain Atrophy is Related to Lacunar Lesions and Tissue Microstructural Changes in CADASIL
Stroke 38:1786-1790, Jouvent, E.,et al, 2012

Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis
NEJM 367:1098-1106,1149, Gold, R.,et al, 2012

Placebo-Controlled Phase 3 Study of Oral BG-12 or Glatiramer in Multiple Sclerosis
NEJM 367:1087-1097,1149, Fox, R.J.,et al, 2012

Monosymptomatic Clinically Isolated Syndrome with Sudden Sensorineural Hearing Loss
The Neurologist 18:302-305, Anagnostouli, M.C.,et al, 2012

Tumefactive Multiple Sclerosis Lesions under Fingolimod Treatment
Neurol 79:2000-2002,1942, Visser, F.,et al, 2012

Severe Relapses under Fingolimod Treatment Prescribed after Natalizumab
Neurol 79:2004-2006,1942, Centonze, D.,et al, 2012

Multiple Sclerosis Rebound Following Herpes Zoster Infection and Suspension of Fingolimod
Neurol 79:2006-2007,1942, Gross, C.M.,et al, 2012

Varicella-Zoster Virus Encephalitis and Vasculopathy in a Patient Treated with Fingolimod
Neurol 79:2002-2004,1942, Ratchford, J.,et al, 2012

Emerging Subspecialties in Neurology: Neuroimmunology
Neurol 79:e178-e180, Clardy, S., 2012

Alemtuzumab for Multiples Sclerosis: Who and When to treat?
Lancet 380:1795-1797, 1792, Springer, T. & Kappos, L., 2012

Should we be nervous about coeliac disease? Brain abnormalities in patients with coeliac disease referred for neurologic opinion
JNNP 83:1216-1221, Currie, S.,et al, 2012

Current Concept of Neuromyelitis Optica (NMO) and NMO Spectrum Disorders
JNNP doi:10.1136/JNNP-2012-302310, Jacob, A.,et al, 2012

Cortical Pathology in Multiple Sclerosis Patients with Epilepsy: A 3 Year Longitudinal Study
JNNP 83:49-54, Calabrese, M.,et al, 2012

Recovery after Spinal Cord Infarcts
Neurol 78:114-121, Robertson,C.E.,et al, 2012

Association Between Immediate Initiation of Intramuscular Interferon Beta-1a at the Time of a Clinically Isolated Syndrome and Long-term Outcomes
Arch Neurol 69:183-190, Kinkel,R.P.,et al, 2012

Fingolimod-Associated Macular Edema
Neurol 78:672-680, Jain,N. and Bhatti,M.T., 2012

Serologic Diagnosis of NMO
Neurol 78:665-671, Waters,P.J.,et al, 2012

Assessing Abnormal Iron Content in the Deep Gray Matter of Patients with Multiple Sclerosis verus Healthy Controls
AJNR 33:252258, Habib,C.A.,et al, 2012

Solitary Sclerosis
Neurol 78:540-544, Schmalstieg,W.F.,et al, 2012

Early Surgical Therapy for Drug-Resistant Temporal Lobe Epilepsy
JAMA 307:922-930,966,985, Engel,J.,et al, 2012

Evidence-based Guideline: Intravenous Immunoglobulin in the Treatment of Neuromascular Disorders
Neurol 78:1009-1015, Patwa,H.S.,et al, 2012

Placebo-Controlled Trial of Oral Laquinimod for Multiple Sclerosis
NEJM 366:1000-1009, Comi,G.,et al, 2012

Neuromyelitis Optica and Pregnancy
Neurol 78:875-879, Bourre,B.,et al, 2012

Diffusion-weighted imaging characteristics of biopsy-proven demyelinating brain lesions
Neurol 78:1655-1662, Abou Zeid, N.,et al, 2012



Showing articles 250 to 300 of 4627 << Previous Next >>